Dexcom G6 CGM, continuous glucose monitoring

NEWS

NEWS

REPORT

New data from Dexcom adds to the proof that wearable

diabetes technology is not costly considering the improvements

it brings to quality of life and improved HbA1c results.

A report - Long-term costeffectiveness

of Dexcom G6 real-time

continuous glucose monitoring versus

self-monitoring of blood glucose in

patients with Type 1 diabetes in the UK,

was recently published in the journal

Diabetes Care (the study was supported

by Dexcom).

The long-term health economic analysis

was undertaken to establish the cost

effectiveness of Dexcom's G6 CGM sensor.

The findings presented provide UK-based

payers (including self-funders and CCGs)

as well as policymakers (hopefully MPs

and higher-ups in the NHS) with valuable

information relating to the cost effectiveness

of this technology. Those resistant to it

might now start to understand the longterm value, and not just

Long-term health economic analyses

suggest that CGM improves glycaemic

control and reduces the risk of longterm diabetes-related

complications.

For patients in the UK with T1D, the G6

CGM device is associated with significant

improvements in clinical outcomes and,

over patient lifetimes, is a cost-effective

disease management option relative to

self-monitoring of blood glucose (SMBG).

The cost-effectiveness of Dexcom

G6 included capturing the 'quality of life'

benefits associated with people with

diabetes having a reduced fear of hypos,

therefore being able to achieve greater

control, as well as calming those who fear

(and therefore do not engage with) fingerpricking to get blood tests. Also shown was

the overall improvement of HbA1c benefit

associated with continued CGM use.

Peter Lynch, vice president of global

CGM cost anyalsis

access at Dexcom, commented on the

results saying, "The results of the UK

Dexcom G6 cost effectiveness analysis,

clearly demonstrates that CGM is not

only good value for money but also a

highly cost-effective intervention for

people with uncontrolled diabetes. This

publication provides NICE with a robust

economic analysis that - along with

our extensive clinical evidence - should

enable them to produce a Technology

Appraisal on the Dexcom G6. This will

support NHS England in providing equal

access to CGM, reducing the inconsistent

prescribing that is currently seen."

Quality of life

Dexcom is one of four industry partners

(the others being Abbott, Insulet and

Roche) in the Pathway to Choice

programme led by Type 1 diabetes charity

JDRF. The first Pathway to Choice report,

launched in February 2020, revealed

that 83% of people affected by Type 1

diabetes would like to use continuous

glucose monitoring through the NHS, but

there are clear barriers to access.

Says Karen Addington, CEO of JDRF

UK "We created the Pathway to Choice

partnership to build awareness and

access to Type 1 technology choices for

people with T1D. Greater choice around

wearable technologies could make a

real difference to people living with this

relentless and demanding condition."

Based on the fear of hypoglycaemia

criterion alone, it is estimated that up to

25% of patients with T1D may be eligible

continued over"This will support NHS

England in providing

equal access to

CGM, reducing

the inconsistent

prescribing that is

currently seen.

- Peter Lynch,

Dexcom

Index

  1. Free online Desang diabetes magazine diabetes information
  2. insulin pump, Dana RS system, artificial pancreas, Advanced Therapeutics UK, CamAPS FX, Dexcom G6
  3. Desang diabetes, magazine diabetes information, Sue Marshall diabetes
  4. Desang diabetes magazine, diabetes news
  5. Desang diabetes magazine diabetes news, Tandem Control IQ
  6. Desang diabetes magazine diabetes news, Diabetes UK Wales
  7. Page 0007
  8. Abbott Freestyle Libre, Flash Glucose Monitoring
  9. Diabetes technology education from Diabetes Technology Network DTN
  10. Abbott Freestyle Libre, Flash Glucose Monitoring
  11. Abbott Freestyle Libre, Flash Glucose Monitoring
  12. Dexcom G6 CGM, continuous glucose monitoring
  13. Dexcom G6 CGM, continuous glucose monitoring
  14. Dexcom CGM G6, continuous glucose monitoring
  15. Medtronic Guardian Connect CGM sensor for diabetes
  16. Diabetes and coronovirus Desang Diabetes Magazine
  17. Diabetes and coronovirus Desang Diabetes Magazine, resources covid-19 and diabetes
  18. Desang diabetes magazine, diabetes diet
  19. Medtronic Minimed 670G hybrid closed loop insulin pump
  20. Desang diabetes magazine, diabetes diet, Dr Will's sauces
  21. Insulet Omnipod DASH insulin pump with insulin pods, podders, Omnipod DASH Personal Diabetes Manager
  22. Vitamin D and diabetes, desang diabetes magazine
  23. Ascensia Contour Next One Diabetes blood test meters
  24. Vitamin D and diabetes, desang diabetes magazine
  25. Medtrum A6 Touchcare patch pump and CGM in harmony
  26. My diabetes Kit, Desang Magazine
  27. My diabetes Kit Max Rapson, Desang Magazine, Captain Lantus
  28. Spirit Health, Spirit Digital, insulin injection devices, blood glucose monitors
  29. Page 0029
  30. Desang Diabetes Magazine, free diabetes magazine, living with diabetes
  31. Desang Diabetes Magazine, free diabetes magazine, living with diabetes
  32. Page 0032
  33. diabetes food news, diabetic diet, counting carbohydrates
  34. Desang Diabetes Magazine, Making Carbs Count, carbohydrate counting for diabetes
  35. Desang Diabetes Magazine, Making Carbs Count, carbohydrate counting for diabetes
  36. Desang Diabetes Magazine, Making Carbs Count, carbohydrate counting for diabetes
  37. Page 0037
  38. Page 0038

Related Issues